Skip Navigation


Nucleic Acids Research Advance Access originally published online on May 25, 2009
Nucleic Acids Research 2009 37(Web Server issue):W606-W611; doi:10.1093/nar/gkp288
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (5482K) Freely available
Right arrow Screen PDF (685K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
37/suppl_2/W606    most recent
gkp288v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Katz, L. S.
Right arrow Articles by Jordan, I. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katz, L. S.
Right arrow Articles by Jordan, I. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2009, Vol. 37, No. suppl_2 W606-W611
© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Articles

Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing data

Lee S. Katz1,*, Chris R. Bolen1, Brian H. Harcourt2, Susanna Schmink2, Xin Wang2, Andrey Kislyuk1, Robert T. Taylor1, Leonard W. Mayer2,* and I. King Jordan1

1School of Biology, Georgia Institute of Technology, Atlanta, GA 30332 and 2Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA

*To whom correspondence should be addressed. Tel: +1 404 385 1264; Fax: +1 404 894 0519; Email: lskatz{at}gatech.edu

Correspondence may also be addressed to Leonard W. Mayer's. Tel: +1 404 639 2841; Fax: +1 404 639 4421; Email: lwm1{at}cdc.gov Correspondence may also be addressed to Leonard W. Mayer. +1 404 639 2841; lwm1{at}cdc.gov

Received January 30, 2009. Revised April 10, 2009. Accepted April 14, 2009.

The Meningococcus Genome Informatics Platform (MGIP) is a suite of computational tools for the analysis of multilocus sequence typing (MLST) data, at http://mgip.biology.gatech.edu. MLST is used to generate allelic profiles to characterize strains of Neisseria meningitidis, a major cause of bacterial meningitis worldwide. Neisseria meningitidis strains are characterized with MLST as specific sequence types (ST) and clonal complexes (CC) based on the DNA sequences at defined loci. These data are vital to molecular epidemiology studies of N. meningitidis, including outbreak investigations and population biology. MGIP analyzes DNA sequence trace files, returns individual allele calls and characterizes the STs and CCs. MGIP represents a substantial advance over existing software in several respects: (i) ease of use—MGIP is user friendly, intuitive and thoroughly documented; (ii) flexibility—because MGIP is a website, it is compatible with any computer with an internet connection, can be used from any geographic location, and there is no installation; (iii) speed—MGIP takes just over one minute to process a set of 96 trace files; and (iv) expandability—MGIP has the potential to expand to more loci than those used in MLST and even to other bacterial species.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.